moxonidine has been researched along with enalapril in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Gräve, MA; Hughes, PR; Jäger, BA; Kaan, EC; Küppers, HE; Luszick, JH | 1 |
| Hughes, PR; Jäger, BA; Küppers, HE; Küster, LJ; Luszick, JH; Prichard, BN; Sauermann, W; Verboom, CN | 1 |
2 trial(s) available for moxonidine and enalapril
| Article | Year |
|---|---|
Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Enalapril; Female; Humans; Hypertension; Imidazoles; Imidazoline Receptors; Male; Middle Aged; Receptors, Drug | 1997 |
Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild to moderate essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Enalapril; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Placebos; Posture; Therapeutic Equivalency | 2002 |
2 other study(ies) available for moxonidine and enalapril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |